Articles that tag CNMD but are mainly about other companies.
AirSeal technology platform shows strong growth potential with only 6-7% penetration of 3M+ U.S. laparoscopic procedures, generating clinical evidence and expanding ASC relationships with expected high-single to low-double-digit long-term growth.
Recognized as a leading electrosurgery manufacturer with opportunities to grow through expanding ambulatory surgical centers and increasing adoption of minimally invasive procedures.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
